Your premier mRNA partner who excels in accelerating the development of revolutionary products of life-science pioneers
Our services
Advanced CDMO services for nanomedicines
Ardena
Ardena is an integrated service CDMO, assisting biopharma companies with services spanning the full development life cycle. The company offers a comprehensive ‘Make, Analyze, File’ model from drug substance and drug product manufacturing and bioanalytical services through to regulatory dossier development.
With a strong reputation for quality and a flexible service delivery model, Ardena caters to a highly diversified base of over 500 customers throughout Europe, the US, Japan and Korea. A high science approach and broad drug development toolkit differentiate Ardena from peers as a comprehensive multi-service pan-European platform.
We work together on:
RIBOPRO provides advanced mRNA and LNP technologies to Ardena’s customers
Ardena support GMP development and regulatory approval of LNP formulations to RiboPro’s customers
Together, we provide an End-to-End solution for RNA therapy pioneers
Interested? Contact our BD-team via our dedicated contact page
RNA Readiness and Response
Wellcome Leap
The Wellcome Leap Health Breakthrough Network (HBNet) is the largest, most rapidly ‘activatable’ health research network in the world. With more than 100 world-class institutions, non-profits and commercial entities representing a network of over 1,000,000 scientists and engineers across six continents, they are able to increase speed and collaboration, reducing barriers to breakthroughs in human health.
We work together on:
Changing the dynamics and costs of development and production
Providing access to cGMP-formulated RNA
Producing at speeds & quantities sufficient for emergency situations
Learn more about Wellcome Leap
GMP-manufacturing sites
Medace
Medace is a Maastricht, the Netherlands, based service provider who helps companies like RIBOPRO start GMP-manufacturing. Medace provides services related to setting up a QMS, provides personnel for QA and manufacturing tasks if needed, takes care of warehousing and offers GMP-compliant cleanrooms (grade A, B and C) for rent.
We work together on:
RiboPro rents GMP-compliant cleanrooms (grade A & C)
Medace provides GMP-compliant warehousing
Medace provides support in setting up RIBOPRO’s QMS
Learn more about Medace
Targeted mRNA therapeutics
Mercurna
Mercurna is a Netherlands-based biotechnology company working on targeted mRNA therapeutics, with candidates for chronic kidney disease (CKD), eye disease, bone-marrow disease, and skin disease in preclinical development. Their most advanced program uses an unique kidney-targeting peptide (glomerulus targeting) with exceptional specificity, targeting a previously unknown receptor.
We work together on:
RiboPro supplies LNP & mRNA technologies to Mercurna
RiboPro manufactures mRNA & LNP for Mercurna
Mercurna provides specialized assays & targeting technology
Learn more about Mercurna
From molecule to patient
Radboudumc
The Radboudumc is based in Nijmegen, the Netherlands, and besides its clinical practises houses more than 45 research departments, of which multiple now use RIBOPRO mRNA for research and therapy development. To ensure commercial viability, Radboudumc and RIBOPRO entered a license agreement focussed that provides a framework for continuous access to RIBOPRO’s patented mRNA technologies.
We work together on (among others):
mRNA-supported CAR-T therapy
Kidney disease
LNP technologies
Learn more about Radboudumc
Partner with Professionals
Partnering with RIBOPRO
Partnering with RIBOPRO, as opposed to te more straight-forward customer-manufacturer relationship that we have with hundreds of customers, provides access to benefits such as priority manufacturing, extra financial/legal/product options, and contract research/co-development projects.
We like to work together on:
mRNA manufacturing (also saRNA, circRNA and next-gen long RNA)
LNP formulation
Enzyme development
Equipment development
Interested? Contact our BD-team via our dedicated contact page
What we do
Our services
We offer a range of services that enable mRNA therapy pioneers to develop the medicines of the future.
From mRNA design, to R&D- and GMP-grade manufacturing of (LNP-formulated) mRNA, and contract research services; our one-stop-shop has you covered.
Even better, our licensable technologies on mRNA design, manufacturing processes and LNP formulations provide a headstart in the competitive marketplace.
How it’s done
Our methods
Through strong internal R&D programs, we develop mRNA and delivery technologies, and supporting production processes, that transcend the state-of-the-art.
Building on more than a decade of mRNA-specific experience, RIBOPRO truly understands mRNA and can help you navigate the choices that lead to best-in-class quality and safety while keeping costs under control. Choices that may affect the entire life cycle of your product.
0
>
years experience in mRNA
0
unique mRNA constructs produced
0
%
success rate
0
>
customers served worldwide
The right tools, attention, and the best ingredients inspire to realize even the biggest dreams.
Sander van AsbeckFounder / CEO
Superior Quality through Continuous Innovation
Our products & services
mRNA manufacturing
High-quality, high-performance mRNA manufactured with the newest techniques, with a short turn-around time
LNP formulation
High-efficiency encapsulation of mRNA into LNPs with control over size, PDI and zeta-potential
Success services
We help design experiments, interpret data and advice how to continue development, so you can be successful.
Real-world evidence
What our customers say
“Initially my results with mRNA were suboptimal, however with the support and dedication from the professionals at RiboPro, I was able to further optimize my experiments in such a way that my experiments turned out more successful.”
Jitske Jansen
Post-doc researcher Radboudumc
We take the work and uncertainty out of developing your own mRNA product, so you can accomplish more
Get in touch today
RiboWorld
Latest articles
Partnership
RIBOPRO and IPA Partner to Advance mRNA-Driven Antibody Discovery, Unlocking New Frontiers in Immunotherapy
Fund raising
RIBOPRO Secures Series A Funding to Accelerate mRNA-Based technologies
Customer Article
Antifibrotic and Pro-regenerative Effects of SMAD3 siRNA and Collagen I mRNA-Loaded Lipid Nanoparticles in Human Tenocytes